Guidelines for hormone treatment of women in the menopausal transition and beyond.
Naftolin
F
F
Schneider
H P G
HP
Sturdee
D W
DW
Birkhäuser
M
M
Brincat
M P
MP
Gambacciani
M
M
Genazzani
A R
AR
Limpaphayom
K K
KK
O'Neill
S
S
Palacios
S
S
Pines
A
A
Siseles
N
N
Tan
D
D
Burger
H G
HG
D002318:Cardiovascular Diseases / Q000517:prevention & control; D002561:Cerebrovascular Disorders / Q000517:prevention & control; D004305:Dose-Response Relationship, Drug; D016889:Endometrial Neoplasms / Q000517:prevention & control; D015914:Estrogen Replacement Therapy / Q000592:standards*; D005260:Female; D006801:Humans; D008593:Menopause / Q000502:physiology*; D015663:Osteoporosis, Postmenopausal / Q000517:prevention & control; D016032:Randomized Controlled Trials as Topic